1. 105669645 曲格列汀及其琥珀酸盐的制备方法
CN
15.06.2016
C07D 401/04 Loading...
C07D 401/04
Loading...
201610091703.9
南京正大天晴制药有限公司
黄俊
C07D 401/04
Loading...
本发明公开了曲格列汀及其琥珀酸盐的制备方法。包括以下步骤：在有机溶剂中，磷酸盐和相转移催化剂存在的条件下，将曲格列汀中间体II与曲格列汀中间体III进行亲核取代反应得到曲格列汀I，再与琥珀酸盐生成盐。本发明的制备方法，操作过程简单安全、无需特种设备，可以大幅降低二取代和伯胺取代异构体的杂质的含量，仅需要一次重结晶，得到的琥珀酸曲格列汀I’纯度即可大于99.5％，二取代和伯胺取代异构体的杂质均小于0.05％，其他所有杂质也均小于0.05％，制得的琥珀酸曲格列汀I’纯度高，生产成本低，适合于工业化生产。
2. 105106976 一种碘克沙醇注射液及其制备方法
CN
02.12.2015
A61K 49/04 Loading...
A61K 49/04
Loading...
201510513894.9
南京正大天晴制药有限公司
郭璇
A61K 49/04
Loading...
本发明属于药物制剂技术领域，公开了一种碘克沙醇注射液及其制备方法。本发明所述的碘克沙醇注射液，其组分含有：碘克沙醇，氯化钠，酒石酸钠，加入注射用水至全量，最后用酸调至合适的pH范围。与现有技术相比，本发明的碘克沙醇注射液中辅料加入的种类和数量大幅减少，注射液的粘度进一步降低，提高了临床病人应用的顺应性。同时，经过高温灭菌试验，低温冻融实验以及刺激性试验等考察，本发明的碘克沙醇注射液质量稳定，血管刺激性小，完全符合安全用药的需求。
3. 105017060 一种沙芬酰胺新晶型及其制备方法
CN
04.11.2015
C07C 237/06 Loading...
C07C 237/06
Loading...
201510386660.2
南京正大天晴制药有限公司
郭璇
C07C 237/06
Loading...
本发明涉及药物化学领域，具体涉及一种沙芬酰胺甲磺酸盐新晶型，即晶型B及其制备方法，还涉及包含该新晶型的药物组合物及其在治疗帕金森疾病中的应用。所述的沙芬酰胺甲磺酸盐晶型B，使用Cu-Kα辐射，以2θ角度表示的X-射线粉末衍射在7.82、8.51、13.01、17.82、18.71、20.37、21.98、22.90处有衍射峰。
4. 203720632 基于物联网技术的中药饮片田间管理系统
CN
16.07.2014
G05B 19/418 Loading...
G05B 19/418
Loading...
201420050356.1
南京中医药大学
胡晨骏
G05B 19/418
Loading...
本实用新型公开了一种基于物联网技术的中药饮片田间管理系统，包括传感器节点、录入终端、路由节点和监控平台，所述传感器节点布置在种植田块内，所述录入终端包括种植田块录入单元、种植品种录入单元、种植时间录入单元、施肥时间和施肥量录入单元、农药喷洒时间和喷洒量录入单元和采收时间录入单元，所述传感器节点和录入终端采集的信息通过路由节点发送至监控平台，所述监控平台对接收到的数据进行存储。本实用新型提供的基于物联网技术的中药饮片田间管理系统，解决了传统的中药材种植生产管理落后局面，人工管理消耗大，中药材原药质量得不到保证等缺陷。
5. 203204422 一种中药饮片生产用智能物联数字化管控系统
CN
18.09.2013
G05B 19/418 Loading...
G05B 19/418
Loading...
201320203042.6
南京海源中药饮片有限公司
蔡宝昌
G05B 19/418
Loading...
本实用新型公开了一种中药饮片生产用智能物联数字化管控系统，包括：用于生产数据处理的服务器端；与所述服务器端连接，用于对饮片炮制器进行智能控制的智能控制台；与所述智能控制台连接，用于加工炮制中药饮片炮制器。本实用新型运用计算机在线控制炮制工艺参数及其他信息，结合炒黄、炒炭、蒸制、蜜炙、醋炙、盐炙、煅制、麸炒等炮制工艺标准流程，可接受电子任务，定制操作规程，实现炮制过程规范化、饮片质量标准化、生产成本节约化，提高了饮片质量，对中药饮片行业炮制工艺的规范化、生产自动化、质量标准化、管理信息化，对中药炮制现代化的发展、对推动中药饮片行业技术进步以及对中药饮片行业国际市场竞争力的提升均有着极其重要的意义。
6. 103268087 一种中药饮片生产用智能物联数字化管控系统及方法
CN
28.08.2013
G05B 19/418 Loading...
G05B 19/418
Loading...
201310139041.4
南京海源中药饮片有限公司
蔡宝昌
G05B 19/418
Loading...
本发明公开了一种中药饮片智能物联数字化控制系统及方法，将现有的炮制电气设备，采用计算机与自动化技术，创新设计智能化可控模块，运用计算机在线控制炮制工艺参数及其他信息，结合炒黄、炒炭、蒸制、蜜炙、醋炙、盐炙、煅制、麸炒等炮制工艺标准流程，可接受电子任务，定制操作规程，实现炮制过程规范化、饮片质量标准化、生产成本节约化。本发明传统的中药饮片炮制赋予了新的生命力，将传统的中药炮制经验描述提高到数字化、标准化；提高饮片质量，对中药饮片行业炮制工艺的规范化、生产自动化、质量标准化、管理信息化，对中药炮制现代化的发展、对推动中药饮片行业技术进步以及对中药饮片行业国际市场竞争力的提升均有着极其重要的意义。
7. 103268534 中药饮片企业生产集成决策支持系统及方法
CN
28.08.2013
G06Q 10/06 Loading...
G06Q 10/06
Loading...
201310206155.6
南京海源中药饮片有限公司
蔡宝昌
G06Q 10/06
Loading...
本发明公开了中药饮片企业生产集成决策支持系统及方法，属于中药饮片生产监控的技术领域。所述系统包括中药饮片企业异构系统，数据集成及决策分析器、数据整合装置、人机交互器、设备监控器、下位机。所述方法通过整合处理中药饮片企业异构信息，实时监测炮制设备工作参数得到中药饮片生产策略，能够及时调整炮制设备工作参数，实现炮制过程规范化；提供客户优化原药材存储、饮片生产、存储及流通等各个环节的依据，提高生产效率。
8. 103191075 他达拉非的口服药物制剂
CN
10.07.2013
A61K 9/20 Loading...
A61K 9/20
Loading...
201310153588.X
南京海融医药科技有限公司
晁阳
A61K 9/20
Loading...
本发明涉及他达拉非的口服药物制剂，及其在治疗男性勃起功能障碍方面的应用。其特征在于主药是他达拉非或其盐，具体剂型为口崩片、咀嚼片或口腔膜剂等在口腔中速释的制剂。他达拉非为难溶性药物，生物利用度比较低，因此服用的无效剂量比较大，会产生多种不良放应，不合理用药可造成视力损伤或丧失。针对他达拉非的药物制剂在提高药物的生物利用度，降低不良反应的发生的研究，对于他达拉非在临床上广泛应用于治疗男性性功能障碍尤为重要。其次，针对他达拉非的药物制剂在患者服用时的顺应性的提高，尤其是在无水的环境下以非吞咽的方式的服用，对广大ED患者来说是很大的福音。本发明正是以患者为本，经过大量研究产生的。
9. 102935089 荔枝螺在制备解热抗炎药物中的应用
CN
20.02.2013
A61K 35/56 Loading...
A61K 35/56
Loading...
201210464740.1
南京中医药大学
唐于平
A61K 35/56
Loading...
本发明公开了荔枝螺在制备解热抗炎药物中的应用。本发明通过大量实验筛选荔枝螺的药理活性，实验结果表明，荔枝螺软体提取物或荔枝螺壳粉对二甲苯致小鼠耳廓肿胀、角叉菜胶致小鼠足跖肿胀的急性炎症模型具有较强的抑制作用，表现出很好的解热、抗炎活性，并且还具有抗氧化能力，增强SOD活力，清除氧自由基，减少丙二醛的释放作用。为充分利用广阔的海洋资源，开发新的安全有效的海洋药物具有重要的意义。
10. 102895261 荔枝螺在制备解热抗炎药物中的应用
CN
30.01.2013
A61K 35/56 Loading...
A61K 35/56
Loading...
201210441375.2
南京中医药大学
唐于平
A61K 35/56
Loading...
本发明公开了荔枝螺在制备解热抗炎药物中的应用。本发明通过大量实验筛选荔枝螺的药理活性，实验结果表明，荔枝螺软体提取物或荔枝螺壳粉对二甲苯致小鼠耳廓肿胀、角叉菜胶致小鼠足跖肿胀的急性炎症模型具有较强的抑制作用，表现出很好的解热、抗炎活性，并且还具有抗氧化能力，增强SOD活力，清除氧自由基，减少丙二醛的释放作用。为充分利用广阔的海洋资源，开发新的安全有效的海洋药物具有重要的意义。
11. WO/2012/126231 USE OF POLY(4-STYRENE SULFONIC ACID-COPOLY-MALEIC ACID) SODIUM SALT AND PHARMACEUTICAL COMPOSITION THEREOF
WO
27.09.2012
A61K 31/795 Loading...
A61K 31/795
Loading...
PCT/CN2011/078371
SUZHOU VIROSEC CO., LTD.
WU, Zhiwei
A61K 31/795
Loading...
Use of poly(4-styrene sulfonic acid-copoly-maleic acid) sodium salt in the preparation of pharmaceutical inhibiting infection of HIV-1 and pharmaceutical composition thereof. Said pharmaceutical composition comprises poly(4-styrene sulfonic acid-copoly-maleic acid) sodium salt as active ingredient and conventional pharmaceutical carrier.
12. WO/2012/094838 USE AND PHARMACEUTICAL COMPOSITION OF LIGNOSULFONATE
WO
19.07.2012
A61K 31/185 Loading...
A61K 31/185
Loading...
PCT/CN2011/070730
NANJING UNIVERSITY
WU, Zhiwei
A61K 31/185
Loading...
The present invention discloses the use and pharmaceutical composition of lignosulfonate. Lignosulfonate has strong activity against HIV-1 in vitro. The mechanism is mainly blocking HIV-1 virus from binding to target cells, thereby blocking its infection. Lignosulfonate also has significant inhibitory effect on the CD4 dependent and in-dependent HIV-1 infection. In addition, the result of cell fusion experiments shows that lignosulfonate has the role of inhibiting HIV-1 viral envelope protein-mediated integration. Finally, cytotoxicity experiments show that lignosulfonate has basic non-toxicity to cells in the effective antiviral concentrations. Lignosulfonate has rich source and low production costs. It can be used as a new potential anti-HIV-1 drug and antimicrobial agent.
13. 102365288 普拉格雷氢溴酸盐的晶体
CN
29.02.2012
C07D 495/04 Loading...
C07D 495/04
Loading...
201080014201.7
上海医药工业研究院
袁哲东
C07D 495/04
Loading...
本申请公开了2-乙酰氧基-5-(α-环丙基羰基-2-氟苄基)-4，5，6，7-四氢噻吩并[3，2-c]吡啶氢溴酸盐的晶体，以及含该晶体的晶体组合物和药物组合物以及其用途。本申请公开的普拉格雷氢溴酸盐晶体具有很好的稳定性及溶解性。
14. 102250088 Salt of N-methylated 8-methoxy ouinolone carboxylic acid compound, preparation method and use thereof
CN
23.11.2011
C07D 471/04 Loading...
C07D 471/04
Loading...
201110115710.5
Nanjing Acean Pharmaceutical Research Co.,Ltd.
Ye Hai
C07D 471/04
Loading...
The invention relates to an N-methylated 8-methoxy ouinolone carboxylic acid compound, an acid addition salt of the N-methylated 8-methoxy ouinolone carboxylic acid compound, an alkali metal salt of a carboxylic acid compound having a structure represented by a formula (I), a preparation method, and a use of the N-methylated 8-methoxy ouinolone carboxylic acid compound in quality control for a quinolone drug of moxifioxacin hydrochloride. According to the present invention, the N-methylated 8-methoxy ouinolone carboxylic acid compound is adopted as an impurity reference substance, a quantitative control is performed for the N-methylated 8-methoxy ouinolone carboxylic acid compound in the industrially-produced moxifioxacin hydrochloride raw material and the industrially-produced formulation so as to facilitate the control of the quality of the industrially-produced moxifioxacin hydrochloride.
15. 102068408 Fasudil hydrochloride injection and preparation method thereof
CN
25.05.2011
A61K 9/08 Loading...
A61K 9/08
Loading...
201010617277.0
Nanjing Xingang Pharmaceutical Co.,Ltd.
Bao Yusheng
A61K 9/08
Loading...
The invention relates to a medicament for improving and preventing symptoms of cerebral vasospasm and cerebral ischemia and preparation method thereof, in particular to a Fasudil hydrochloride injection and a preparation method thereof, which are characterized in that: the Fasudil hydrochloride injection contains Fasudil hydrochloride with the concentration of between 2 and 10 mg/ml and a pharmaceutically acceptable diluent; and the preparation method is characterized by comprising the following steps of: regulating the pH value to be between 5.5 and 7.0 by using 0.1 to 1.0 mol/l solution of sodium hydroxide and hydrochloric acid, and filling the solution into a brown container. The prepared Fasudil hydrochloride injection is stable in quality, safe and effective and effectively solves the problem of reasonable medication of patients who suffer from renal dysfunction by adopting new clinical using specifications.
16. 201796275 中药饮片生产智能物联控制系统
CN
13.04.2011
G05B 19/418 Loading...
G05B 19/418
Loading...
201020504130.6
南京海昌中药饮片有限公司
蔡宝昌
G05B 19/418
Loading...
中药饮片生产智能物联控制系统，包括服务器、饮片炮制器，还包括：参数的跟踪、保存模块；智能控制器；智能控制器管理饮片炮制器，采用过程控制的手段，可以充分保证各种参数的精确控制；实时监控模块；通过实时监控模块实时采集关键数据，可以及时发现超过警戒值的数据后进行报警，可以通过远程控制或现场更改的方式在最短的时间内对饮片炮制器进行修正控制；上述各部分通过局域网或工业控制线连接，数据实时汇总在服务器。本实用新型的有益效果在于可以制定饮片的质量标准，提高饮片质量，可追溯历史生产纪录，确保临床用药安全有效。
17. WO/2010/111951 CRYSTALS OF PRASUGREL HYDROBROMATE
WO
07.10.2010
C07D 495/04 Loading...
C07D 495/04
Loading...
PCT/CN2010/071464
SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
YUAN, Zhedong
C07D 495/04
Loading...
The crystals of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrobromate, crystal compositions and pharmaceutical compositions containing them and their use are disclosed. The crystals of prasugrel hydrobromate of the present application possess excellent stability and solubility.
18. 101851164 Composite method of substituted ethyl benzoylacetate containing fluorine and nitrogen
CN
06.10.2010
C07C 205/56 Loading...
C07C 205/56
Loading...
201010185442.X
Nanjing Acean Medicine Co., Ltd.
Huo Liru
C07C 205/56
Loading...
The invention provides a composite method of substituted ethyl benzoylacetate containing fluorine and nitrogen, comprising: taking benzoyl chloride containing substituted fluorine, nitryl and N-alkylbenzene as a starting material; reacting with diethyl malonate to obtain benzoyl diethyl malonate containing the substituted fluorine, nitryl and N-alkylbenzene; and finally, hydrolyzing to obtain the target product. The amino target product only needs to reduce nitryl functional group hydrogen. The whole composite process is stable, produces few byproducts, fundamentally has no pollution and can realize industrialized production.
19. 101843580 Preparation method of pidotimod injection preparation
CN
29.09.2010
A61K 9/00 Loading...
A61K 9/00
Loading...
201010180714.7
Nanjing Acean Medicine Co., Ltd.
Huo Liru
A61K 9/00
Loading...
The invention discloses a preparation method of a pidotimod injection preparation, which is characterized by utilizing alkaline cosolvent tris-hydroxy-methyl-aminomethane to dissolve pidotimod, and has the advantages that the pH value of the solution does not need to be adjusted, an optimal pH value can be obtained after the completeness of the preparation, the operation is convenient and time-saving, and the method is easy for industrialized production.
20. 101830845 Synthesis method of 5-chloro-2,3-dihydroxyl pyridine
CN
15.09.2010
C07D 213/69 Loading...
C07D 213/69
Loading...
201010185434.5
Nanjing Dahai Pharmaceutical Co., Ltd.
Huo Liru
C07D 213/69
Loading...
The invention provides a synthesis method of 5-chloro-2,3-dihydroxyl pyridine. The method comprises the following steps of: using 2-amino-5-chloropyridine as a starting material; diazotizing to prepare 2-hydroxy-5-chloropyridine; then nitrifying to generate 2-hydroxy-3-nitro-5-chloropyridine and reducing into 2-hydroxy-3-amino-5-chloropyridine; and finally diazotizing to prepare the target product 2,3-dyhydroxy-5-chloropyridine.
21. WO/2010/045755 GLYCOSYL-DERIVATIVES OF PUERARIN, PHARMACEUTICAL COMPOSITON, PREPARATION METHOD AND USE THEREOF
WO
29.04.2010
C07H 17/07 Loading...
C07H 17/07
Loading...
PCT/CN2008/001799
NANJING NORMAL UNIVERSITY
DING, Xuansheng
C07H 17/07
Loading...
Glycosyl-derivatives of puerarin presented by formula (I) or pharmaceutically acceptable salts thereof, wherein R is monosaccharides (6-carbon saccharides or 5-carbon saccharides) or oligosaccharyl (2-5 glycosyl selected from 6-carbon saccharides or 5-carbon saccharides); the pharmaceutically acceptable salts is inorganic or organic base addition salts. The glycosyl-derivatives of puerarin in the present invention or pharmaceutically acceptable salts thereof maintain higher stability and solubility, improve bioavailability and enhance therapeutic effect compared with puerarin.

